Abstract

Background Pneumonia is a common disease among the aging population in Japan. Hence, it is important to elucidate the risks related to pneumonia mortality. Since Streptococcus pneumoniae is the most commonly observed pathogen, pneumococcal vaccination is recommended to older adults. Therefore, this study aimed to clarify the clinical features of pneumonia, including the status of pneumococcal vaccination, in hospitalized older adult patients in Japan. Methods This single-centered retrospective study was conducted by reviewing the medical records of all patients with acute pneumonia at Fujisawa City Hospital in Japan from April 2018 to March 2019. Patients were divided into two groups based on their history of pneumococcal vaccination. The primary endpoint was in-hospital mortality, while the secondary endpoint was risk factors associated with mortality. Results We included 93 patients with pneumonia in this retrospective study. Although the mortality rate was higher in the vaccinated group (15.8%) than in the unvaccinated group (9.1%), vaccination status was not identified as a significant risk factor for mortality after multivariable logistic regression (odds ratio: 2.71; 95% confidence interval: 0.667–11.02; p=0.16). In addition, the A-DROP score was identified as an independent risk factor (odds ratio: 2.64; 95% confidence interval: 1.22–5.72; p=0.008). Conclusions Our study suggested that the A-DROP score is a risk factor of mortality for pneumonia in older adults. In addition, pneumococcal vaccination history was related to increased mortality; however, the influence of the vaccination remains unclear because of the small sample size.

Highlights

  • Pneumonia is a common disease among the aging population in Japan

  • It was reported that the effects of PPV23 and PCV13 were limited against nonbacteremic pneumonia [6,7,8,9,10]. is study aimed to clarify the clinical features of pneumonia in hospitalized older adult patients in Japan and investigated how pneumococcal vaccination was related to pneumonia. is study has been presented in accordance with the STROBE reporting checklist

  • Vaccinated patients received influenza vaccinations more frequently than unvaccinated patients (86.8% vs. 27.3%, p < 0.001). ere were no differences in hypertension, diabetes, heart disease, kidney disease, neurological disease, and cancer observed between the two groups, but vaccinated patients had a relatively higher prevalence of respiratory disease (68.4% vs. 49.1%, p 0.06)

Read more

Summary

Introduction

Pneumonia is a common disease among the aging population in Japan. there is rapid progress in its treatment, pneumonia remains one of the leading causes of death. It is important to elucidate the risk factors for pneumonia related to death. Some clinical trials have investigated the effects of these vaccines in preventing pneumococcal pneumonia and reducing the risk of mortality [2,3,4]. Is study aimed to clarify the clinical features of pneumonia in hospitalized older adult patients in Japan and investigated how pneumococcal vaccination was related to pneumonia. Since Streptococcus pneumoniae is the most commonly observed pathogen, pneumococcal vaccination is recommended to older adults. Erefore, this study aimed to clarify the clinical features of pneumonia, including the status of pneumococcal vaccination, in hospitalized older adult patients in Japan. Our study suggested that the A-DROP score is a risk factor of mortality for pneumonia in older adults. Pneumococcal vaccination history was related to increased mortality; the influence of the vaccination remains unclear because of the small sample size

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call